2i3i

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
{{Seed}}
 
[[Image:2i3i.png|left|200px]]
[[Image:2i3i.png|left|200px]]
Line 20: Line 19:
==About this Structure==
==About this Structure==
-
2I3I is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2I3I OCA].
+
[[2i3i]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2I3I OCA].
==Reference==
==Reference==
Line 29: Line 28:
[[Category: Apoptosis inhibition]]
[[Category: Apoptosis inhibition]]
[[Category: Drug design]]
[[Category: Drug design]]
 +
[[Category: Inhibitor/apoptosis complex]]
[[Category: Peptide complex]]
[[Category: Peptide complex]]
[[Category: Peptidomimetic]]
[[Category: Peptidomimetic]]
[[Category: Small molecule]]
[[Category: Small molecule]]
[[Category: Zinc binding]]
[[Category: Zinc binding]]
- 
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 18 03:36:28 2009''
 

Revision as of 00:23, 15 March 2011

Template:STRUCTURE 2i3i

Structure of an ML-IAP/XIAP chimera bound to a peptidomimetic

Template:ABSTRACT PUBMED 17168540

About this Structure

2i3i is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Zobel K, Wang L, Varfolomeev E, Franklin MC, Elliott LO, Wallweber HJ, Okawa DC, Flygare JA, Vucic D, Fairbrother WJ, Deshayes K. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs. ACS Chem Biol. 2006 Sep 19;1(8):525-33. PMID:17168540 doi:10.1021/cb600276q
  • Vucic D, Franklin MC, Wallweber HJ, Das K, Eckelman BP, Shin H, Elliott LO, Kadkhodayan S, Deshayes K, Salvesen GS, Fairbrother WJ. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Biochem J. 2005 Jan 1;385(Pt 1):11-20. PMID:15485396 doi:10.1042/BJ20041108
  • Franklin MC, Kadkhodayan S, Ackerly H, Alexandru D, Distefano MD, Elliott LO, Flygare JA, Mausisa G, Okawa DC, Ong D, Vucic D, Deshayes K, Fairbrother WJ. Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP). Biochemistry. 2003 Jul 15;42(27):8223-31. PMID:12846571 doi:10.1021/bi034227t

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools